Home > Insider Trading > Filing (0001237899-11-000050)

Filing Details

Accession Number:: 0001237899-11-000050
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-09-02 16:45:25
Reporting Period:: 2011-08-31

Filing Date:: 2011-09-02
Accepted Time:: 2011-09-02 16:45:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1013064	Roy P Vagelos	777 Old Saw Mill River Road Tarrytown NY 10591	Chairman Of The Board	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-08-31	312,500	$28.01	452,587	No	4	M	Direct
Common Stock	Disposition	2011-08-31	143,587	$60.96	309,000	No	4	F	Direct
Common Stock	Disposition	2011-08-31	76,458	$60.96	232,542	No	4	F	Direct
Common Stock	Disposition	2011-09-01	3,500	$60.00	229,042	No	4	S	Direct
Common Stock	Disposition	2011-09-02	35,968	$60.35	193,074	No	4	S	Direct
Common Stock	Disposition	2011-09-02	29,529	$61.42	163,545	No	4	S	Direct
Common Stock	Disposition	2011-09-02	23,458	$62.04	140,087	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2011-08-31	312,500	$0.00	312,500	$28.01

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2002-12-18	2011-12-18	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,271	Indirect	By 401(k) Plan
Common Stock	175,056	Indirect	by CLAT
Common Stock	94,222	Indirect	by GRAT
Common Stock	160,000	Indirect	by Spouse as Trustee
Common Stock	1,203	Indirect	by trust for grandch

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 3,500 shares of Company stock on September 1, 2011 at prices ranging from $60.00 to $60.03. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 1, 2011 at each separate price.
Represents volume-weighted average price of sales of 35,698 shares of Company stock on September 2, 2011 at prices ranging from $60.00 to $60.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 2, 2011 at each separate price.
Represents volume-weighted average price of sales of 29,529 shares of Company stock on September 2, 2011 at prices ranging from $61.06 to $61.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 2, 2011 at each separate price.
Represents volume-weighted average price of sales of 23,458 shares of Company stock on September 2, 2011 at prices ranging from $62.01 to $62.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 2, 2011 at each separate price.
By an irrevocable trust for the benefit of grandchildren of the reporting person, of which the spouse of the reporting person is trustee.
By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case.